Vyripharm Biopharmaceuticals, Inc.
11
Jeffrey P Norman
01/27/2025
12/18/2025
Yes
v
| PlnDue, DsclsDue |
Assigned to: Bankruptcy Judge Jeffrey P Norman Chapter 11 Voluntary Asset |
|
Debtor Vyripharm Biopharmaceuticals, Inc.
7205 Almeda Road, Suite 300591 Houston, TX 77054 HARRIS-TX Tax ID / EIN: 85-4177026 |
represented by |
Susan Tran Adams
Tran Singh LLP 2502 La Branch Street Houston, TX 77004 832-975-7300 Fax : 832-975-7301 Email: stran@ts-llp.com |
Trustee Melissa A Haselden
Haselden Farrow PLLC Pennzoil Place 700 Milam Suite 1300 Houston, TX 77002 832.819.1149 |
| |
U.S. Trustee US Trustee
Office of the US Trustee 515 Rusk Ave Ste 3516 Houston, TX 77002 713-718-4650 |
represented by |
Hector Duran, Jr
U.S. Trustee 515 Rusk Ste 3516 Houston, Tx 77002 7137184650 Email: Hector.Duran.Jr@usdoj.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 12/18/2025 | 56 | Order Converting Confirmation Hearing to Status Conference Signed on 12/18/2025 (Related document(s):[42] Chapter 11 Small Business Subchapter V Plan) (trc4) |
| 11/05/2025 | 55 | Notice of Hearing. (Related document(s):[42] Chapter 11 Small Business Subchapter V Plan, [54] Courtroom Minutes) Filed by Vyripharm Biopharmaceuticals, Inc. (Attachments: # (1) Service List) (Adams, Susan) |
| 11/03/2025 | 54 | Courtroom Minutes. Time Hearing Held: 9:30. Appearances: Susan Tran for debtor, Subchapter V Trustee Melissa Haselden, U.S. Trustee Andrew JimenezJ. (Related document(s):[1] Voluntary Petition (Chapter 11)) Status Conference held. Parties agreed to continue hearing for payments. Confirmation hearing to be held on 12/22/2025 at 09:00 AM at Houston, Courtroom 403 (JPN). (srh4) |
| 10/31/2025 | 53 | BNC Certificate of Mailing. (Related document(s):[52] Generic Order) No. of Notices: 2. Notice Date 10/31/2025. (Admin.) |
| 10/29/2025 | 52 | Order Converting Chapter 11 Plan Confirmation Hearing to a Status Conference Signed on 10/29/2025 (Related document(s):[42] Chapter 11 Small Business Subchapter V Plan) (trc4) |
| 10/23/2025 | 51 | Debtor-In-Possession Monthly Operating Report for Filing Period ending 9/30/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan) |
| 10/23/2025 | 50 | Debtor-In-Possession Monthly Operating Report for Filing Period ending 8/31/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan) |
| 09/19/2025 | By Email Agreement - Hearing Continued (Related document(s):[42] Chapter 11 Small Business Subchapter V Plan) Confirmation hearing to be held on 11/3/2025 at 09:30 AM at Houston, Courtroom 403 (JPN). (trc4) | |
| 09/18/2025 | 49 | Witness List, Exhibit List (Filed By Vyripharm Biopharmaceuticals, Inc. ).(Related document(s):[42] Chapter 11 Small Business Subchapter V Plan, [47] Courtroom Minutes) (Attachments: # (1) Exhibit 1 - Second Amended Subchapter V Plan of Vyripharm Biopharmaceuticals, Inc. [Docket No. 42] # (2) Exhibit 2 - Revised Plan Payment Schedule (Exhibit 1 to Plan) # (3) Exhibit 3 - Revised General Unsecured Creditor Plan Payment Schedule (Exhibit 2 to Plan) # (4) Exhibit 4 - Ballot Summary [Docket No. 43] # (5) Exhibit 5 - Vyripharm Enterprises, Incs Market Forecast # (6) Exhibit 6 - Vyripharm Enterprises, Inc.s Sources and Uses 10/31/2025 Funding # (7) Exhibit 7 - Vyripharm Enterprise, Inc. Investor Letter of Intent) (Adams, Susan) |
| 08/20/2025 | 48 | PDF with attached Audio File. Court Date & Time [ 8/20/2025 9:29:52 AM ]. File Size [ 2989 KB ]. Run Time [ 00:06:14 ]. (admin). |